Health
Looking beyond COVID-19’s spike protein for the next wave of vaccines – FierceBiotech
Most ongoing vaccine development efforts against the novel coronavirus focus on the spike protein on the surface of SARS-CoV-2. But a team led by immuno-oncology specialist TScan Therapeutics found that memory CD8+ T cells from recovered patients mainly targe…
Most ongoing vaccine development efforts against the novel coronavirus use the spike protein on the surface of SARS-CoV-2 in the hopes of inducing neutralizing antibodies that can directly block the virus from infecting healthy cells. But there could be one major caveat to that approach: The antibody response to the virus, mediated by B cells of the immune system, appears to wane quickly.
Thats why a research team led by immuno-oncology biotech TScan Therapeutics turned to another key component…
-
General19 hours ago‘We are here for you’: PM to bring help to flood zones
-
Business15 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
General18 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
General15 hours agoStephanie Scott’s murder caused a ‘seismic’ shock in Leeton, and the hurt remains